Digoxin Is Associated With Improved Transplant-Free Interstage Survival In High-Risk But Not Low-Risk Patients With Hypoplastic Left Heart Syndrome (Hlhs)

Tyler Brown, David Brown,James S. Tweddell,Katherine Bates,Carole Lannon,Jeffrey Anderson

JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY（2020）

Cited 2|Views22

No score

Abstract

Digoxin use has been associated with lower interstage mortality in infants with HLHS and variants. The NEONATE score was developed to risk stratify patients for interstage mortality or transplantation; risk factors included type of stage 1 palliation (S1P)—Norwood with BT or Sano shunt vs. Hybrid

Translated text

Key words

hypoplastic left heart syndrome,hlhs,transplant-free,high-risk,low-risk

AI Read Science

Must-Reading Tree

Example

Generate MRT to find the research sequence of this paper

Chat Paper

Summary is being generated by the instructions you defined